Although different and not standardized criteria and end‐points were applied to the numerous studies performed, a pooled analysis of 1587 patients with LR‐MDS demonstrated ESA response rate of 39.5%, based on Hb increases of 1 g/dL or greater or achievement of transfusion independence (TI).39 The gene discussed is GSTM1; the disease is myelodysplastic syndrome.